Cardiovascular disease and statin drugs
Campbell, A.W.
Alternative Therapies in Health and Medicine 20(5): 8-9
2014
ISSN/ISBN: 1078-6791 PMID: 25141364 Document Number: 675593
Document emailed within 1 workday
Related Documents
Mittal, M.; Fay, W.P. 2013: Almost everyone over 50 should be put on a statin to reduce the risk of cardiovascular disease: a contrarian view Missouri Medicine 110(4): 339-341Nanchen, D.; Chiolero, A.; Marques-Vidal, P-Manuel.; Cornuz, J.; Waeber, Gérard.; Vollenweider, P.; Rodondi, N. 2010: Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland? Revue Medicale Suisse 6(239): 488-90 492-3
Nilsson, P.; Erhardt, L. 2001: An extensive English study: reduced cardiovascular mortality and morbidity by statin Lakartidningen 98(51-52): 5846-5850
Stiffman, M.N. 1997: "Statin" drugs, mortality, and stroke prevention Journal of Family Practice 45(4): 293-294
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72
Fretheim, A.; Bjørndal, A.; Oxman, A.D.; Dyrdal, A.; Golding, M.; Ose, L.; Reikvam, A.; Teisberg, P. 2002: Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(23): 2287-2288
Malcolm, L. 1990: Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease New Zealand Medical Journal 103(896): 402-404
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61
Bangalee, V; Suleman, F 2016: Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health Sa Gesondheid 21: 60-66
Liu, L-Ping.; Wang, Y-Jun. 2011: Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease Zhonghua Nei Ke Za Zhi 50(4): 275-277
Follath, F. 1999: New cardiovascular drugs: expanded therapeutic possibilities in coronary heart disease and in heart failure Praxis 88(18): 809-813
Danchin, N.; Amelineau, E.; Quentzel, S.; Cambou, J.P. 2006: Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey Annales de Cardiologie et d'Angeiologie 55(1): 17-21
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Costello, M.; Shrestha, B.; Eden, J.; Sjoblom, P.; Johnson, N. 2007: Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Cochrane Database of Systematic Reviews 1: Cd005552
Kłosiewicz-Latoszek, L.; Respondek, W.; Białobrzeska-Paluszkiewicz, J.; Grzybowska, B.; Jakóbisiak-Ostasz, B.; Stolarska, I. 2003: Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 42-46
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Thorogood, M. 1993: Anticonceptivos orales y enfermedad cardiovascular - Oral contraceptives and cardiovascular disease Beneficios y Riesgos de la Anticoncepcion Oral. Simposio (Caracas 1992-11) 9: 19-29
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6